Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Conservative management of streptococcal necrotizing periorbital fasciitis following primary VZV infection.

Il Giornale di chirurgia·2020

Same author

A novel and effective ophthalmology morbidity and mortality meeting.

Eye (London, England)·2018

Same author

Ranibizumab versus dexamethasone implant for central retinal vein occlusion: special remarks of the RANIDEX study.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2017

Same author

Diabetic retinopathy: pathogenesis, clinical grading, management and future developments.

Diabetic medicine : a journal of the British Diabetic Association·2012

Same author

Injectability of silicone oil-based tamponade agents.

The British journal of ophthalmology·2010

Same author

Triamcinolone-assisted vitreous imaging using B-scan ultrasonography.

European journal of ophthalmology·2008

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

Vitreoretinal interface changes in acute-onset postoperative endophthalmitis.

S A Kabanarou¹, T Xirou, C Kourentis

¹Department of Ophthalmology, Korgialenio-Benakio, Red Cross Hospital, Athens, Greece. stamatina_k@hotmail.com

Klinische Monatsblatter Fur Augenheilkunde

|April 23, 2009

Summary

This summary is machine-generated.

Assessing the vitreoretinal interface in acute postoperative endophthalmitis surgery is crucial. Early intervention and cautious vitreous cortex removal in specific cases improve visual outcomes and reduce complications like phthisis.

More Related Videos

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Published on: March 7, 2025

Related Experiment Videos

Last Updated: Jun 23, 2026

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Published on: March 7, 2025

Area of Science:

Ophthalmology
Surgical Management
Vitreoretinal Interface

Background:

Acute postoperative endophthalmitis presents with varying clinical signs.
The vitreoretinal interface's appearance can indicate disease severity.
Understanding these changes is key for effective surgical planning.

Purpose of the Study:

To evaluate the significance of clinical presentations of the vitreoretinal interface.
To determine the impact of these findings on surgical management strategies.
To assess the prognostic value of intraoperative observations.

Main Methods:

Vitrectomy was performed on 22 patients with acute postoperative endophthalmitis.
Patients were grouped based on vitreoretinal interface changes: Group A (mild), Group B (moderate), Group C (severe).
Surgical approach varied, including cautious vitreous cortex removal in Group A.

Main Results:

Visual acuity improved in 14 patients, remained stable in 2, and deteriorated in 6.
Group A showed a better visual prognosis compared to Groups B and C.
Groups B and C had higher rates of phthisis (37.5% and 50%) and no retinal detachments occurred.

Conclusions:

Intraoperative assessment of the vitreoretinal interface is vital for managing endophthalmitis.
The degree of vitreoretinal insult has prognostic implications.
Tailoring surgical management based on interface appearance optimizes patient outcomes.